The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable angina
- 31 August 2004
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 15 (5) , 291-297
- https://doi.org/10.1016/j.ejim.2004.06.002
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Phospholipase A2The Journal of Biochemistry, 2002
- Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease.Clinical Biochemistry, 2001
- Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor–Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E–Deficient MiceCirculation, 2001
- Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteinsThe American Journal of Medicine, 2001
- Role of novel markers of inflammation in patients with stable coronary heart diseaseThe American Journal of Cardiology, 2001
- Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart DiseaseNew England Journal of Medicine, 2000
- Oxidized Lipoproteins Degrade the Endothelial Surface LayerCirculation, 2000
- Platelet-Activating Factor Acetylhydrolase Prevents Myocardial Ischemia-Reperfusion InjuryCirculation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Protection against Oxidative Stress-induced Cell Death by Intracellular Platelet-activating Factor-Acetylhydrolase IIJournal of Biological Chemistry, 1997